share_log

Should You Investigate Edwards Lifesciences Corporation (NYSE:EW) At US$90.34?

Should You Investigate Edwards Lifesciences Corporation (NYSE:EW) At US$90.34?

你是否應該以90.34美元的價格調查愛德華茲生命科學公司(紐約證券交易所代碼:EW)?
Simply Wall St ·  05/22 22:12

Edwards Lifesciences Corporation (NYSE:EW) received a lot of attention from a substantial price movement on the NYSE over the last few months, increasing to US$95.56 at one point, and dropping to the lows of US$84.30. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether Edwards Lifesciences' current trading price of US$90.34 reflective of the actual value of the large-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let's take a look at Edwards Lifesciences's outlook and value based on the most recent financial data to see if there are any catalysts for a price change.

愛德華茲生命科學公司(紐約證券交易所代碼:EW)在過去幾個月中因紐約證券交易所的價格大幅波動而受到廣泛關注,一度漲至95.56美元,跌至84.30美元的低點。一些股價走勢可以爲投資者提供更好的入股機會,並有可能以較低的價格買入。需要回答的問題是,愛德華茲生命科學目前的90.34美元交易價格是否反映了大盤股的實際價值?還是它目前的估值被低估了,爲我們提供了買入的機會?讓我們根據最新的財務數據來看看愛德華茲生命科學的前景和價值,看看是否有任何價格變動的催化劑。

What Is Edwards Lifesciences Worth?

愛德華茲生命科學值多少錢?

The stock seems fairly valued at the moment according to our valuation model. It's trading around 18.23% above our intrinsic value, which means if you buy Edwards Lifesciences today, you'd be paying a relatively fair price for it. And if you believe that the stock is really worth $76.41, then there isn't really any room for the share price grow beyond what it's currently trading. Although, there may be an opportunity to buy in the future. This is because Edwards Lifesciences's beta (a measure of share price volatility) is high, meaning its price movements will be exaggerated relative to the rest of the market. If the market is bearish, the company's shares will likely fall by more than the rest of the market, providing a prime buying opportunity.

根據我們的估值模型,該股票目前似乎估值合理。它的交易價格比我們的內在價值高出約18.23%,這意味着如果你今天收購愛德華茲生命科學,你將爲此支付相對合理的價格。而且,如果你認爲該股的實際價值爲76.41美元,那麼股價在目前的交易價格之外實際上沒有任何上漲的餘地。但是,將來可能會有機會購買。這是因爲愛德華茲生命科學的貝塔值(衡量股價波動的指標)很高,這意味着其價格相對於其他市場的價格走勢將被誇大。如果市場看跌,該公司的股票下跌幅度可能會超過其他市場,這提供了絕佳的買入機會。

What does the future of Edwards Lifesciences look like?

愛德華茲生命科學的未來是什麼樣子?

earnings-and-revenue-growth
NYSE:EW Earnings and Revenue Growth May 22nd 2024
紐約證券交易所:EW 收益和收入增長 2024 年 5 月 22 日

Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Buying a great company with a robust outlook at a cheap price is always a good investment, so let's also take a look at the company's future expectations. Edwards Lifesciences' earnings over the next few years are expected to increase by 45%, indicating a highly optimistic future ahead. This should lead to more robust cash flows, feeding into a higher share value.

尋求投資組合增長的投資者可能需要在購買公司股票之前考慮公司的前景。以低廉的價格收購一家前景看好的優秀公司永遠是一項不錯的投資,因此,讓我們也來看看公司的未來預期。愛德華茲生命科學未來幾年的收益預計將增長45%,這表明未來的前景非常樂觀。這應該會帶來更強勁的現金流,從而提高股票價值。

What This Means For You

這對你意味着什麼

Are you a shareholder? It seems like the market has already priced in EW's positive outlook, with shares trading around its fair value. However, there are also other important factors which we haven't considered today, such as the financial strength of the company. Have these factors changed since the last time you looked at the stock? Will you have enough conviction to buy should the price fluctuates below the true value?

你是股東嗎?看來市場已經對EW的樂觀前景進行了定價,股票的交易價格接近其公允價值。但是,我們今天還沒有考慮其他重要因素,例如公司的財務實力。自從你上次查看股票以來,這些因素是否發生了變化?如果價格波動低於真實價值,您是否有足夠的信心買入?

Are you a potential investor? If you've been keeping an eye on EW, now may not be the most advantageous time to buy, given it is trading around its fair value. However, the positive outlook is encouraging for the company, which means it's worth diving deeper into other factors such as the strength of its balance sheet, in order to take advantage of the next price drop.

你是潛在的投資者嗎?如果你一直在關注EW,那麼鑑於EW的交易價格接近其公允價值,現在可能不是最有利的買入時機。但是,樂觀的前景令該公司感到鼓舞,這意味着值得深入研究其他因素,例如資產負債表的強度,以便利用下一次價格下跌的機會。

If you want to dive deeper into Edwards Lifesciences, you'd also look into what risks it is currently facing. At Simply Wall St, we found 1 warning sign for Edwards Lifesciences and we think they deserve your attention.

如果你想更深入地研究愛德華茲生命科學,你還需要研究它目前面臨的風險。在 Simply Wall St,我們發現了 Edwards Lifesciences 的 1 個警告標誌,我們認爲它們值得你關注。

If you are no longer interested in Edwards Lifesciences, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

如果您不再對愛德華茲生命科學感興趣,可以使用我們的免費平台查看我們列出的其他50多隻具有高增長潛力的股票清單。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論